Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: JACC Cardiovasc Interv. 2014 Jun 18;7(7):707–716. doi: 10.1016/j.jcin.2014.01.167

Figure 1. Survival, heart failure symptoms, and quality of life at 1 year in patients treated with TAVR in the PARTNER trial.

Figure 1

Data shown is from the PARTNER Trial (8-11). Abbreviations: NYHA, New York Heart Association; QoL, quality of life.